GHMS yields 3.83% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, GHMS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GHMS + JNJ for your $10,000?
GHMS aims for income by using various proprietary models to invest in fixed income securities including other ETFs. Each fund respectively invests in US and non-US corporate bonds, government securities, and agency and mortgage-backed securities. The underlying ETFs may invest in debt securities of any credit rating or maturity. Utilizing rules-based, quantitative systems in combination with discretionary analysis, the adviser measures market risk to select funds. Adjustments to exposure is based on an analysis supported by proprietary models that may utilize factors, such as momentum and trend, market structure, volatility, cross-asset signals, seasonality, and fundamentals. To hedge duration and interest rate risk, the fund may invest up to 20% of its assets in futures contracts on sovereign bonds or fixed income indexes. The actively managed fund allows the portfolio manager full discretion to adjust the portfolio at any time.
Full GHMS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.